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Clara Cell protein and myeloperoxidase levels in serum of subjects
after exposure to fire smoke
Stężenie białka Clara i mieloperoksydazy w surowicy osób narażonych na dymy
pożarowe
Praca była finansowana z funduszy własnych autorów. Praca była realizowana w ramach programu statutowego IMP w Łodzi
pt. ”Poszukiwanie biomarkerów skutków narażenia układu oddechowego na czynniki drażniące uwalniane w trakcie pożarów”.
Abstract
Introduction. Fire smoke inhalation is a well-recognized aetiological factor of airway injuries. The objective of this study was
evaluation of Clara cell protein (CC16) and myeloperoxidase (MPO) concentrations in serum of patients after exposure to
uncontrolled fire smoke.
Methods. The study group consisted of 40 consecutive patients admitted to the Toxicology Unit after exposure to fire smoke.
CC16 and MPO concentrations in their serum samples was measured on the day of admission to hospital and rechecked at the
2nd day and on the day of discharge. Patients also underwent routine toxicological diagnostic procedures applied in case of
exposures, such as carboxyhaemoglobin (COHb) levels and blood lactate and urinary thiocyanate concentrations. The same
diagnostic tests were performed in the control group consisting of 10 healthy subjects not exposed to fire smoke.
Results. The average concentration of CC16 in the serum of subjects exposed to toxic factors was significantly higher at the
day of admission in comparison with the respective values recorded on the 2nd day and on the day of discharge. The mean
level of CC16 in the serum of the exposed group was also significantly higher than that in the control group. Tests for MPO
concentrations in the serum did not reveal any significant changes in patients exposed to fire smoke.
Conclusions. As indicated, acute exposure to smoke induces injury at the alveolar level, which results in a transient
increase of CC16 in serum of exposed subjects.
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Streszczenie
Wstęp. Narażenie na dymy pożarowe jest udokumentowaną przyczyną toksycznego uszkodzenia układu oddechowego.
Celem badania była ocena stężeń bialka Clara i mieloperoksydazy w surowicy osób narażonych na dymy pożarowe.
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Introduction
Exposure to the variety of agents emitted du-
ring fire accidents may result in acute injuries of
airways. The major chemicals released during com-
bustion and pyrolysis processes are: nitrogen and
sulphur dioxides, aldehydes, carbon monoxide
(CO), and halogenated hydrocarbons [1].. Some of
them can exhibit direct toxicity to the respiratory
tract. A study evaluating respiratory symptoms in
a group of firefighters showed a higher intensity
of symptoms after prolonged contact with fire smo-
ke [2]. Such exposure may lead to the development
of inflammation of upper and lower airways. Gau-
ghan et al. [3] found that respiratory symptoms or
changes in the results of lung function tests obse-
rved in subjects involved in firefighting were as-
sociated with increased myeloperoxidase (MPO)
and eosinophilic cationic protein (ECP) levels in
sputum and nasal lavage fluid. These data confirm
the important role of neutrophil inflammation and
the neutrophil-related enzyme in the pathogene-
sis of acute upper and lower respiratory symptoms
in this group.
The role of CC16 as a protein marker of seve-
rity of airway injuries after exposure to irritants is
well documented [4]. This protein, known also
under other names like uteroglobine in rabbits, is
produced in humans mainly by Clara cells locali-
sed in terminal bronchioles; however, some studies
have shown that this protein may be synthesised
by non-ciliated cells along the tracheobronchial
epithelium [5] and in the urogenital tract, particu-
larly in the prostate [5]. Although this protein may
be secreted by the male urogenital tract, the lung
seems to be the predominant, if not the exclusive
source of serum CC16. The CC16 plays both an
immunosuppressive and anti-inflammatory role in
the lung. It also prevents degradation of lung sur-
factant phospholipids and inhibits production of
Metody. Grupę badaną stanowiło 40 osób narażonych na dymy pożarowe, które zostały przyjęte na oddział toksykologii.
Stężenia białka Clara i mieloperoksydazy oznaczono w dniu przyjęcia do szpitala oraz ponownie w drugim i ostatnim dniu
hospitalizacji. U pacjentów wykonano także badania toksykologiczne zlecane przy tego typu narażeniu: stężenie karboksyhe-
moglobiny i stężenie mleczanów we krwi oraz stężenie rodanków w moczu. Podobny panel badań zlecono u 10 zdrowych
osób (grupa kontrolna) nienarażonych na dymy pożarowe.
Wyniki. Stężenie białka Clara było istotnie statystycznie wyższe w surowicy pacjentów narażonych na dymy pożarowe
w dniu ich przyjęcia do szpitala w porównaniu z wartością tego parametru ocenianego w drugim i ostatnim dniu hospitaliza-
cji. Stężenie białka Clara było również istotnie wyższe w surowicy osób narażonych w porównaniu z grupą kontrolną. Nie
obserwowano istotnych zmian steżenia MPO w surowicy osób eksponowanych na dymy pożarowe.
Wnioski. Narażenie na dymy pożarowe może prowadzić do uszkodzenia pęcherzyków płucnych, a tym samym do wzrostu
w surowicy osób narażonych stężenia białka Clara uwalnianego przez te komórki.
Słowa kluczowe: białko Clara, mieloperoksydaza, uszkodzenie płuc, pożar, strażacy
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interferon-g [6]. CC16 is also thought to participa-
te in the detoxication of some substances deposi-
ted in the respiratory tract [6].
The question addressed by the present study
was whether the extent of acute respiratory injury
caused by acute exposure to fire smoke corre-
sponds with alterations in serum CC16 and MPO
levels.
Material and methods
Subjects and exposure
Forty consecutive patients from a large town,
immediately after accidental exposure to fire smo-
ke, were admitted to the Toxicology Unit between
January and December 2009. The main source of
exposure was uncontrolled fire in dwelling house
or flat, resulting from careless handling of stoves,
cigarettes, or charcoal grills. Patients spent at le-
ast 15–20 minutes in the atmosphere containing
a mixture of harmful gases and fumes produced by
the combustion and pyrolysis of some plastics,
wood, fabric, and other substrates. The average age
in the group of patients exposed to harmful fumes
and gases released during fire smoke was 49.75 ±
16.48 years. Sixteen of them (40%) were smokers
at the time of study or in the past.
The control group consisted of 10 healthy in-
dividuals.
The Regional Bioethical Committee approved
the study protocol and all the participants submit-
ted their written consent prior to the study.
Clinical symptoms
Each patient was examined for the presence
and intensity of the following symptoms; cough,
wheeze, sputum production, and shortness of bre-
ath on exertion, as well as ocular, nasal, and pha-
ryngeal symptoms. Additionally, the following
symptoms and signs of poisoning with carbon
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monoxide were analysed: headache, dizziness,
chest pain, syncope, nausea and vomiting, confu-
sion or agitation, stupor or coma, and seizures (data
not shown).
Laboratory tests
Carboxyhaemoglobin (COHb) levels, arterial
blood gases (ABG), Full Blood Count (FBC), urina-
ry thiocyanate levels, and serum lactate concen-
trations in serum were evaluated on admission to
the hospital. Haemoglobin levels, White Blood Cell
and Red Blood Cell (WBC and RBC) counts, lacta-
te, pH, pO2, pCO2, BE, and thiocyanate levels were
used for further analysis.
Clara cell protein determination
CC16 concentration in serum was measured
using a latex immunoassay [7] with the specific
rabbit antibody against CC16 protein 1 (Dako A/S,
Denmark). The serum samples were pre-treated by
heating for 30 minutes at 56°C and addition of
polyethylene glycol 600 (16%, v/v 1/1) and trichlo-
roacetic acid (10%, v/v, 1/40) to eliminate possi-
ble interference (complement, chylomicrons). The
samples were centrifuged after sedimentation for
10 minutes at 200 g and CC16 was determined in
the supernatant.
Myeloperoxidase determination
MPO in serum was measured using commer-
cially available enzyme-linked immunosorbent
assay (ELISA) [Quantikine human MPO immuno-
assay; R@D Systems, Minneapolis, MN].
Principle of the assay
The assay employs the quantitative sandwich
enzyme immunoassay technique. A monoclonal
antibody specific for MPO was precoated into
a microplate. Standards and samples are pipetted
into the wells, and any MPO present was bound
by the immobilized antibody. After washing away
any unbound substances, an enzyme-linked polyc-
lonal antibody specific for MPO was added to the
wells. Following a wash to remove any unbound
antibody-enzyme reagent, a substrate solution was
added to the wells and colour developed in pro-
portion to the amount of MPO bound in the initial
step. The colour development was stopped and the
intensity of the colour was measured.
Statistical analysis
Results are expressed as mean values ± SD
Results of physical examination and toxicolo-
gical and biochemical tests on the 1st day of hospi-
talization in the group of subjects exposed to toxic
substances and the control group were compared
using the Mann-Whitney test.
The results of tests for CC16 and MPO perfor-
med on the 1st and 2nd days and on the day of di-
scharge in the group of subjects exposed to fire
were compared with those obtained in the control
group using Tamhane’s test .
Pearson’s correlation coefficient was applied
to evaluate the relationship between CC16 concen-
tration and arterial blood gas analysis in the group
of subjects exposed to fire.
A p value < 0.05 was considered as significant.
Results
Twenty-eight patients (70%) complained of at
least one pathologic symptom associated with the
exposure. The most frequently observed problems
on admission in this group included symptoms of
lower airways, reported by 21 patients (52.5% of the
studied cohort). These included dyspnoea, which
was noted in 21 cases (52.5%), and cough in 12 ca-
ses (30%). Nasal or pharyngeal symptoms were re-
corded in 14 (35%) cases and symptoms associated
with conjunctivitis in 9 (22.5%) cases (Table 1).
The average level of COHb in the studied gro-
up constituted 6.77 ± 6.37% of total haemoglobin,
whereas in the control group it was 1.63 ± 0.57%,
respectively. The mean concentrations of thiocy-
anates and lactates in the group of hospitalized
patients were 5.84 ± 7.12 mg/l and 2.05 ± 2.84
mmol/l, respectively (Table 2).
COHb levels and thiocyanate concentrations
were significantly higher in the group of patients
exposed to toxic gases and fumes compared to the
controls (p < 0.05) (Table 2).
The highest concentration of CC16 in the exa-
mined group, 18.61 ± 11.84 mg/l, was noted on the
admission day (the 1st day of hospitalization).
It tended to decrease gradually to 16.70 ± 10.58 mg/l
on the second day of hospitalization and subsequ-
ently 13.41 ± 8.27 mg/l on the day of discharge
(Figure 3).
The average concentration of CC16 in the con-
trol group was 10.67 ± 2.08 mg/l, and was signifi-
cantly lower (p < 0.05) than the concentration re-
corded on the first day of hospitalization in the
serum of patients exposed to toxic substances. Li-
kewise, the concentration of CC16 in the serum of
28 symptomatic subjects from the exposed group
was significantly higher (p < 0.05) than in the con-
trols (Figure 3).
Mean serum MPO levels in the examined gro-
up did not significantly change throughout their
stay at the hospital. Mean serum MPO levels in the
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hospitalized patients did not differ significantly
from those found in the serum of the controls
(Figure 4).
The study revealed a strong correlation betwe-
en concentrations of CC16 on the first day of ho-
spitalization and levels on the 2nd day and the day
of discharge (Table 3).
Concentrations of CC16 in the serum of sub-
jects exposed to toxic agents measured on the
2nd day showed positive correlation with levels
on the 1st day and also with partial pressure of
carbon dioxide (pCO2) checked on the 1
st day
(Table 3).
Concentrations of CC16 measured on the day
of discharge in the studied group displayed positi-
ve correlation with such parameters from the
1st day as CC16 concentration and pCO2 and also
with CC16 concentration on the 2nd day (Table 3).
Table 1. Symptoms reported by subjects exposed to toxic substances released during uncontrolled fire
Tabela 1. Objawy zgłaszane przez osoby narażone na substancje toksyczne uwalniane podczas pożaru
Symptoms/Objawy Number/% of the group
Liczba/% badanej grupy
Total group/cała grupa
n = 40 (100%)
Symptomatic subjects (positive for at least one symptom associated with exposure) 28 (70%)
Osoby zgłaszające objawy (co najmniej jeden objaw związany z narażeniem)
Ocular symptoms/objawy oczne 9 (22.5%)
Upper airways (nasal or pharyngeal) symptoms/górne drogi oddechowe (objawy ze strony nosa lub gardła) 14 (35%)
Lower airways symptoms/total/objawy ze strony dolnych dróg oddechowych/wszystkie zgłaszne 21 (52.5%)
Dyspnoea/duszność/Cough/kaszel 12 (30%)
n — number of subjects/liczba osób
Table 2. Results of physical examination and toxicological and biochemical tests at rest (the 1st day of hospitalization) in
the group of subjects exposed to toxic substances released during uncontrolled fire and the control group
Tabela 2. Wyniki badania przedmiotowego, badań toksykologicznych i biochemicznych w grupie osób narażonych na sub-
stancje toksyczne uwalniane w trakcie pożaru w pierwszym dniu hospitalizacji oraz w grupie kontrolnej
Parameter analysed Subjects exposed to fire smoke Control group P value*
Analizowany parametr Osoby narażone Grupa kontrolna
na dymy pożarowe n = 10
n = 40 Mean ± SD
Mean ± SD Średnia ± SD
Średnia ± SD
Heart rate/częstość pracy serca 90.10 ± 16.32 82.70 ± 11.93 0.138
Systolic blood pressure/skurczowe ciśnienie tętnicze [mm Hg] 130.63 ± 27.20 119.00 ± 9.36 0.022*
Diastolic blood pressure/rozkurczowe ciśnienie tętnicze [mm Hg]
C0Hbg%/karboksyhemoglobina [g%] 6.77 ± 6.37 1.63 ± 0.57 0.001*
Thiocyanates/rodanki [mg/l] 5.84 ± 7.12 0.00 0.001*
Lactates/mleczany mmol/l [0,5–2,2 N] 2.05 ± 2.84 1.55 ± 0.46 0.858
pH [7.35–7.45] 7.38 ± 0.07 7.41 ± 0.02 0.102
P02 [80.0–100.0 mm Hg] 72.94 ± 3.95 61.53 ± 22.33 0.264
pC02  [35.0–45.0 mmHg] 36.51 ± 8.99 37.97 ± 3.62 0.113
BE [mmol/l] –2.89 ± 2.29 –0.96 ± 1.39 0.002*
Hgb [12–17g/dl] 14.0 ± 1.51 15.81 ± 1.04 0.000*
WBC [4.0–10.0 × 103/ml] 9.05 ± 2.72 8.26 ± 2.08 0.574
RBC [3.9–5.5 × 103/ml] 4.35 ± 0.51 5.18 ± 0.36 0.000*
n — number of subjects/liczba osób
*significant < 0.05 compared to control
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Discussion
A number of studies have dealt with the se-
arch for diagnostic tools measuring non-invasive-
ly the extent of lung inflammation during recent
decades [8, 9]. Such works evaluated the integrity
of the pulmonary epithelium from increased serum
concentration of proteins synthesized and physio-
logically detected mainly within the respiratory
tract, e.g. CC16 [10]. This protein, secreted by the
respiratory epithelium, increasingly appears to at-
tenuate the inflammatory response within the re-
spiratory tract [11]. This is produced mainly by
Clara cells, which are localized mainly in the pro-
ximal or central portion of the pulmonary acinus,
at the junction between the conducting airways
and the exchange area [12]. CC16 inhibits both
monocyte and polymorphonuclear neutrophil che-
motaxis and phagocytosis in vitro [12–14]. The
determination of CC16 in serum is a sensitive mar-
ker for detection of early changes in the lung/
/epithelial barrier permeability and/or evaluation of
the integrity of Clara cells that constitute a parti-
cular target for many pneumotoxicans, as has
been shown in various clinical and laboratory stu-
dies [15].
The highest observed concentration of CC 16
in our study was detected on the admission day in
the group of subjects exposed to fire, and it tended
to decrease gradually during the hospital stay. The
average concentration of CC16 in the control gro-
up was significantly lower than that measured on
the first day of hospitalization both in the investi-
gated group and in 28 symptomatic subjects. The
study additionally revealed a strong correlation
between concentrations of CC16 on the first day
of hospitalization and its levels on the 2nd day and
the day of discharge. Concentrations of CC16 in the
serum of subjects exposed to toxic agents, measu-
red on the 2nd day, showed positive correlation with
levels checked on the 1st day and pCO2 on the arte-
rial blood gases test also measured on the 1st day.
The increased concentration of CC16 in our
study directly after the exposure to fire smoke may
be explained by increased airways permeability,
which resulted from exposure to the toxic agents
Figure 3. The concentration of CC16 in the serum of subjects exposed to fire smoke (SEFS) and in the controls
Rycina 3. Stężenie CC16 w surowicy osób narażonych na dymy pożarowe oraz w grupie kontrolnej
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Table 3. Correlation between CC 16 and p02, pC02 indicators in the subjects exposed to toxic substances released during
uncontrolled fire
Tabela 3. Zależność pomiędzy CC16 a p02, pC02 w grupie osób narażonych na substancje toksyczne uwalniane w trakcie pożaru
Analysed parameter CC6 mg/l CC16 mg/l CC16 mg/l day P02 PC02
Analizowany parametr 1st day 2nd day of discharge [mm Hg] [mm Hg]
Pierwszy dzień Drugi dzień Dzień wypisu
CC6 mg/l 1st day 1.000 RS = 0.742 RS = 0.471 RS = –0.017 RS = 0.157
p = 0.000* p = 0.002* p = 0.919 p = 0.334
CC16 mg/l 2nd day RS = 0.742 1.000 RS = 0.698 RS = –0.216 RS = 0.335
p = 0.000* p = 0000* p = 0.181 p = 0.035*
CC16 mg/l day of discharge RS = 0.471 RS = 0.698 1.000 RS = -0.062 RS = 0.329
p = 0.002* p = 0.000* p = 0.153 p = 0.038*
P02 [mm Hg] RS = –0.017 RS = –0.216 RS = –0.062 1.000 RS = –0.298
p = 0.919 p = 0.181 p = 0.702 p = 0.062
PC02 [mm Hg] RS = 0.157 RS = 0.335 RS = 0.329 RS = –0.298 1.000
p = 0.334 p = 0.035* p = 0.038* p = 0.062
*significant p < 0.05 compared to control
Figure 4. The concentration of myeloperoxidase in the serum of subjects exposed to fire smoke (SEFS) and in the controls
Rycina 4. Stężenie MPO w surowicy osób narażonych na dymy pożarowe oraz w grupie kontrolnej
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emitted during the fire. Bernard et al. [16] recor-
ded a transient increase of serum CC16 in the sam-
ples from firefighters after 20 minutes of smoke
inhalation. What is important, this change was fo-
und in the absence of any functional signs of lung
impairment. Other authors also found serum
CC16 to be highly sensitive to lung epithelium
injury in a study performed on cyclists exposed
to ambient O3 [17].
Similarly, an acute exposure of mice and rats
to O3 produced a transient dose-dependent ele-
vation of CC16 in serum, which also paralleled
the elevation of albumin in bronchoalveolar la-
vage [11].
Mean serum MPO concentrations in our stu-
dy did not significantly change in the group of
subjects exposed to fire smoke during their stay
in the hospital and also did not differ significan-
tly from the concentrations measured in the se-
rum of the controls. The highest concentration of
MPO was observed in the serum of 28 hospitali-
zed symptomatic patients at admission; however,
these concentrations did not differ significantly
to those measured subsequently throughout the-
ir hospital stay. These data indicate that inhala-
tion of fire smoke may be responsible for the de-
velopment of an inflammatory response, which is
characterized by neutrophil recruitment to the
lower respiratory tract and release of MPO. This
glycoprotein synthesised by neutrophils and mo-
nocytes catalyses the hydrogen peroxide-depen-
dent formation of reactive species [18] and there-
fore plays an important role in pulmonary inflam-
mation. Conversely to our data, Gaughan at al. [3]
found a rise in MPO concentrations in sputum and
nasal lavage fluid of firefighters showing respira-
tory symptoms.
The most frequent complaints on admission
in the group of subjects exposed to fire included
lower airway symptoms such as dyspnoea and co-
ugh. Gaughan et al. [3] described a relationship
between respiratory symptoms resulting from
exposure to toxic substances emitted during the
fire in a group of firefighters with a decrease in
forced expiratory volume in one second (FEV1).
The irritants released during the fire may in-
duce increased airway resistance, by nerve stimu-
lation and by release of histamine, with consequ-
ent respiratory symptoms, e.g. coughing, wheezing,
shortness of breath, and changes in pulmonary
function [19, 20].
In our study we concentrated on the patho-
physiological effects of irritant gases; therefore,
toxicity of carbon monoxide and cyanides was
not the main subject of the study. Moreover, we
did not observe a predominant pattern of cyani-
de or carbon monoxide toxicity in the examined
group. These two gases are released during un-
controlled fire in varying concentrations depen-
ding on the substrates undergoing combustion,
and they may contribute to the overall toxicity
of fire smoke [1]. The group of patients exposed
to toxic gases and fumes showed significantly
higher COHb levels and thiocyanate concentra-
tions on admission compared with the control
group. COHb formation is a well-recognized ef-
fect of exposure to carbon monoxide [21]. Incre-
ased levels of this form of haemoglobin indicate
that the possibility of carbon monoxide poiso-
ning should always be considered after exposu-
re to fire smoke, and COHb levels should be ro-
utinely checked in such cases. On the other
hand, relatively low levels of COHb and no cli-
nical signs of carbon monoxide poisoning may
suggest that in our group this kind of exposure
did not play an important role.
A similar question should be raised about the
contribution of cyanide toxicity. Direct measure-
ment of cyanide concentration in blood is not fe-
asible; therefore, determination of urinary thiocy-
anates (cyanide metabolites) has become a useful
diagnostic tool in this kind of poisoning [22]. Sta-
tistically significant differences in thiocyanate le-
vels between the studied group and the controls
point to obvious exposure to those toxins.
Conclusions
 Acute exposure to smoke results in an incre-
ase of CC16 in serum of exposed subjects. Serum
CC16 seems to be an important marker for detec-
tion of acute airway injuries caused by smoke.
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